Mutation of TP53 confers ferroptosis resistance in lung cancer through the FOXM1/MEF2C axis. Peng M, Hu Q, Wu Z, Wang B, et al. Am J Pathol 2023 May 24:S0002-9440(23)00173.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peng M, Hu Q, Wu Z, Wang B, et al. Mutation of TP53 confers ferroptosis resistance in lung cancer through the FOXM1/MEF2C axis. Am J Pathol 2023 May 24:S0002-9440(23)00173.
PMID: 37236507